Conference Paper: Effect of core promoter/precore mutation pattern and early virologic response on efficacy outcomes with telbivudine in HBeAg-negative chronic hepatitis B
| Title | Effect of core promoter/precore mutation pattern and early virologic response on efficacy outcomes with telbivudine in HBeAg-negative chronic hepatitis B |
|---|---|
| Authors | Naoumov, N Lai, CL Gane, E Liaw, YF Thongsawat, S Wang, YM Heathcote, EJ Rasenack, J Bzowej, N Chao, G Brown, N |
| Issue Date | 2006 |
| Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep |
| Citation | Journal of Hepatology, v. 44 n. Suppl 2, p. S276-277 [How to Cite?] |
| ISSN | 0168-8278 2011 Impact Factor: 9.264 2011 SCImago Journal Rankings: 0.765 |
| dc.contributor.author | Naoumov, N |
|---|---|
| dc.contributor.author | Lai, CL |
| dc.contributor.author | Gane, E |
| dc.contributor.author | Liaw, YF |
| dc.contributor.author | Thongsawat, S |
| dc.contributor.author | Wang, YM |
| dc.contributor.author | Heathcote, EJ |
| dc.contributor.author | Rasenack, J |
| dc.contributor.author | Bzowej, N |
| dc.contributor.author | Chao, G |
| dc.contributor.author | Brown, N |
| dc.date.accessioned | 2010-09-25T19:34:20Z |
| dc.date.available | 2010-09-25T19:34:20Z |
| dc.date.issued | 2006 |
| dc.identifier.citation | Journal of Hepatology, v. 44 n. Suppl 2, p. S276-277 [How to Cite?] |
| dc.identifier.epage | 277 |
| dc.identifier.hkuros | 122336 |
| dc.identifier.issn | 0168-8278 2011 Impact Factor: 9.264 2011 SCImago Journal Rankings: 0.765 |
| dc.identifier.issue | Suppl 2 |
| dc.identifier.openurl | ![]() |
| dc.identifier.spage | 276 |
| dc.identifier.uri | http://hdl.handle.net/10722/101059 |
| dc.identifier.volume | , v. 44 n. Suppl 2 |
| dc.language | eng |
| dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep |
| dc.relation.ispartof | Journal of Hepatology |
| dc.rights | Journal of Hepatology. Copyright © Elsevier BV. |
| dc.title | Effect of core promoter/precore mutation pattern and early virologic response on efficacy outcomes with telbivudine in HBeAg-negative chronic hepatitis B |
| dc.type | Conference_Paper |


